Back to Our Insights
Special collection

McKinsey on Healthcare: Perspectives on the pandemic

Since early 2020, the healthcare industry has been on the frontlines of seeking solutions for COVID-19.
Evaluating impact | Vaccines and therapeutics | Vulnerable communities | Reflections

Part I

Evaluating the critical care and workforce impact

Article

The next normal arrives: Trends that will define 2021—and beyond
– The COVID-19 pandemic has changed the world, and its effects will last. Here are some factors that business leaders should keep... in mind as they prepare for the next normal.
Article

All in the mix: Why US COVID-19 cases rose and fell, and what comes next
– Some people get out and about more than others. That might be a key and overlooked factor in recent declines in US COVID-19 case... counts—and could have implications as society reopens.
Article

Nursing in 2021: Retaining the healthcare workforce when we need it most
– How healthcare stakeholders can understand, support, and empower the nursing workforce in the wake of the global health crisis.
Article

Not the last pandemic: Investing now to reimagine public-health systems
– The COVID-19 crisis reminds us how underprepared the world was to detect and respond to emerging infectious diseases. Smart investments... of as little as $5 per person per year globally can help ensure far better preparation for future pandemics.

Part II

Vaccines and therapeutics: What we learned

Article

COVID-19 vaccines meet 100 million uncertain Americans
– More than 100 million Americans are uncertain about vaccination. Public- and private-sector leaders can take action to support... adoption, including incremental investment in the range of $10 billion.
Article

On pins and needles: Tracking COVID-19 vaccines and therapeutics
– Key stakeholders will need to continue to monitor and adapt to new data and new variants emerging across the globe to respond... effectively.
Article

‘None are safe until all are safe’: COVID-19 vaccine rollout in low- and middle-income countries
– Despite persistent supply issues, in-country delivery and demand for COVID-19 vaccines is likely to be the next challenge for... LMICs.

Part III

Vulnerable communities and understanding the mental health impact

Article

Returning to resilience: The impact of COVID-19 on mental health and substance use
– As governments race to contain COVID-19, it is important to know the actions society can take to mitigate the behavioral health... impact of the pandemic and economic crisis.
Article

Insights on racial and ethnic health inequity in the context of COVID-19
– McKinsey’s Center for Societal Benefit through Healthcare shares insights on underlying health inequities that contribute... to the disproportionate impact of COVID-19 on communities of color and vulnerable populations.
Article

Rebuilding clinician mental health and well-being after COVID-19
– The pandemic has exacerbated existing issues around the mental health of healthcare workers. Providers can learn from other industries... to develop an integrated framework promoting overall well-being.
Article

COVID-19 and rural communities: Protecting rural lives and health
– Near-term actions can help rural communities as they manage the pandemic on three fronts: treating serious COVID-19 cases, curbing... further spread of the virus, and addressing mental health and social needs.

Part IV

Reflections on the next chapter

Article

Telehealth: A quarter-trillion-dollar post-COVID-19 reality?
– Strong continued uptake, favorable consumer perception, and tangible investment into this space are all contributing to the continued... growth of telehealth in 2021. New analysis indicates telehealth use has increased 38X from the pre-COVID-19 baseline.
Article

Trends that will define 2021 and beyond: Six months on
– In January 2021, we discussed how the COVID-19 pandemic could change the economy. How did we do?
Article

When will the COVID-19 pandemic end?
– Europe and the United States have entered the endemic stage of the COVID-19 outbreak: the virus is widespread, is significantly... less fatal than it was in 2020, and is spurring only limited changes in public behavior. These endemic conditions are likely to continue through the summer and autumn, unless and until immunity-evading new variants emerge. As immunity wanes, however, the next stage remains highly uncertain. In this update, we discuss the outlook, the current and potential future use of boosters and therapeutics, and the shifts in response strategies to the COVID-19 crisis around the world. We also introduce the McKinsey COVID-19 Immunity Index—a tool for understanding a community’s current level of risk from the disease.
Article

Who’s left? Engaging the remaining hesitant consumers on COVID-19 vaccine adoption
– While more Americans receive and show openness to receiving the COVID-19 vaccine, concerns persist among guardians of children... and other cautious segments.
Article

Pandemic to endemic: How the world can learn to live with COVID-19
– With prospects of herd immunity fading, endemic COVID-19 is upon us, and new “whole of society” approaches are needed.

Connect with our Healthcare Systems & Services Practice

Contact